Followers | 827 |
Posts | 119564 |
Boards Moderated | 15 |
Alias Born | 09/05/2002 |
Thursday, February 17, 2022 12:47:11 PM
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ALGS News
- Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 04/30/2024 08:05:00 PM
- Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study • GlobeNewswire Inc. • 04/25/2024 08:05:00 PM
- Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024 • GlobeNewswire Inc. • 04/09/2024 12:00:00 PM
- Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies • GlobeNewswire Inc. • 03/27/2024 12:00:00 PM
- Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/12/2024 08:05:00 PM
- Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024 • GlobeNewswire Inc. • 03/05/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:44:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:42:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:35:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:33:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:31:16 PM
- Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024 • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024 • GlobeNewswire Inc. • 02/20/2024 01:00:00 PM
- Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments • GlobeNewswire Inc. • 02/13/2024 01:00:00 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 01/30/2024 12:04:23 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 01/25/2024 11:12:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 11:06:59 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/28/2023 09:01:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:05:32 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/17/2023 09:38:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:01:52 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 11/07/2023 05:03:26 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM